Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001104659-24-043795

Chief Medical Officer acquired 61,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Deliargyris Efthymios Chief Medical Officer 2024-04-02 Grant or award +61,000 409,433 D
Derivatives
Deliargyris Efthymios Chief Medical Officer 2024-04-02 Grant or award · Stock Option (Right to Buy) +86,000 86,000 D
Loading xslF345X05/tm2411149-3_4seq1.xml…